FRANKLIN LAKES, N.J., Sept. 27, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched BD® Research Cloud, a cloud-based ...
PARIS & PHILADELPHIA--(BUSINESS WIRE)--METAFORA biosystems, a company that’s leveraging its AI-powered flow cytometry platform to generate improved IVDs and more effective cell therapies, today ...
To schedule time for flow analysis, call 977-8877. Leave a message if you are unable to reach us immediately and we will return your call as soon as possible. Users are also welcome to stop by the ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of new NovoExpress software that introduces integrated compliance tools for NovoCyte flow ...
Cytek Biosciences, Inc. has launched the Cytek® Muse® Micro, an enhanced version of its original Guava® Muse® cell analyzer, aimed at making advanced cell analysis more accessible and affordable. The ...
Subjectivity in flow-cytometry data analysis has long been a challenge. Recent advancements in high-speed camera capabilities have led to the integration of morphological features with traditional ...
Comprehensive digital guide to high-throughput screening (HTS) by cytometry, featuring assays, application data, and more Introduction to HTS cytometry and the all-in-one software solution for data ...
What are cell and gene therapies? Cell and gene therapies are utilized to treat diseases and, in some cases, cure diseases by targeting the underlying proteins or genes. Overlaps between these ...
Around the same time, Mack Fulwyler, an engineer working at Los Alamos National Laboratory, needed to separate particles, so he drew on existing techniques to create droplets to separate cells from a ...
Compensation refers to correcting a phenomenon called fluorescence spillover in flow cytometric analysis. This is the removal of the signal of any given fluorochrome from all detectors except the one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results